CAT No: CP26211
CAS No:1147996-34-6
Synonyms/Alias:1147996-34-6;Fmoc-Ile-Ser(Psi(Me,Me)pro)-OH;Fmoc-Ile-Ser(Psime,Mepro)-OH;Fmoc-Ile-Ser[Psi(Me,Me)Pro]-OH;(4S)-3-[(2S,3S)-2-(9H-fluoren-9-ylmethoxycarbonylamino)-3-methylpentanoyl]-2,2-dimethyl-1,3-oxazolidine-4-carboxylic acid;(4S)-3-(Fmoc-Ile)-2,2-dimethyl-oxazolidine-4-carboxylic acid;MFCD11974984;HY-P2410;Fmoc-Ile-Ser(Psi(Me ,Me)pro)-OH;AKOS025289425;Fmoc-L-Ile-L-Ser(Psi(Me,Me)pro)-OH;AS-59380;DA-53312;FF111363;CS-0133753;E70842;S-1147996-34-6;(4S)-3-[(2S,3S)-2-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)-3-methylpentanoyl]-2,2-dimethyl-1,3-oxazolidine-4-carboxylic acid;(S)-3-(N-(9-Fluorenylmethyloxycarbonyl)-L-isoleucinyl)-2,2-dimethyloxazolidine-4-carboxylic acid;
1. Immune-awakening Saccharomyces-inspired nanocarrier for oral target delivery to lymph and tumors
2. High fat diet and GLP-1 drugs induce pancreatic injury in mice
5. Cationic cell-penetrating peptides are potent furin inhibitors
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.